{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiabwztfyt72hdl22xmqd3zqpqxhgvyo5fsypyn3g35hfwzgcbu7ma",
    "uri": "at://did:plc:7vzn242g4tv2qo33vwrpwew4/app.bsky.feed.post/3mihtqkmftcr2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidw4q3saqcfvtgqtxs45fx5rq424ml3drpyfkdduq6b4fd623fgvy"
    },
    "mimeType": "image/jpeg",
    "size": 18663
  },
  "path": "/article/news/local/texas/texas-ibogaine-research-program-unable-drug-company-partner/269-164c7307-f6f0-48eb-b3b4-87d1fa5e7460",
  "publishedAt": "2026-04-01T23:15:20.000Z",
  "site": "https://www.kvue.com",
  "tags": [
    "texas",
    "news",
    "local",
    "home"
  ],
  "textContent": "Last year, state lawmakers set aside $50 million for research into the psychoactive drug, which can treat opioid withdrawal and other mental health conditions.",
  "title": "Texas launching ibogaine research program after failing to find drug company partner"
}